ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø

Àü¹®¼¾ÅÍ ³ú½Å°æ¼¾ÅÍ
Áø·á°ú Á¤½Å°Ç°­ÀÇÇаú HOME

Àü¹®Áø·áºÐ¾ß

³ëÀÎÁ¤½ÅÀÇÇÐ(Ä¡¸Å, ¿ì¿ï, ºÒ¾È, ºÒ¸é, Á¤½Åº´), ±âºÐÀå¾Ö

ÀüÈ­ ¿¹¾à 1522-2500

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2024-09-30 ~ 2024-10-05)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ÇØ´ç ÀÇ·áÁøÀÇ ÁöÁ¤µÈ ½ºÄÉÁìÀÌ ¾ø½À´Ï´Ù.
¿ÀÈÄ

ÇзÂ

ÇзÂ

1985¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ Çлç

1995¼­¿ï´ëÇб³ ´ëÇпø ÀÇÇÐ ¼®»ç

1999¼­¿ï´ëÇб³ ´ëÇпø ÀÇÇÐ ¹Ú»ç

°æ·Â

°æ·Â

~ 1996¼­¿ï´ëÇб³º´¿ø ¼ö·Ã ¹× Àü°øÀÇ ¼ö·á

2015 ~ 2017ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø Á¤½Å°Ç°­ÀÇÇаú °úÀå

2012 ~ ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø Á¤½Å°Ç°­ÀÇÇаú ±³¼ö

¼ö»óÀÌ·Â

¼ö»óÀÌ·Â

º¸°Ç»çȸºÎÀå°ü»ó ¼ö»ó

³í¹®/Àú¼­

³í¹®/Àú¼­
´ëÇ¥ ³í¹® ¹× Àú¼­
1. ³ëÀÎÁ¤½ÅÀÇÇÐ °³Á¤ÆÇ-´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸÆí (°øÀú, 2004)

2. ¸ÓÅ© ¸Å´º¾ó ³ëÀκ´ÇÐ. (°ø¿ª, 2003)

3. CARDS manual (2003)

4. Á¤½ÅÀå¾ÖÀÇ ÀÌÇØ (1997) ¿Ü Àú¼­ 7±Ç°ú Çмú³í¹® 52Æí(±¹Á¦ 24/±¹³» 28)

5. Çѱ¹ Àα¸ÀÇ ³ë·ÉÈ­¿Í Ä¡¸Å: Àå·¡ Ãß°è¿Í Àü¸Á.(02)

6. Dementia in Korea: Trend and Projection(02)

7.Diagnostic Capability of the Cognitive Assessment and Reference Diagnoses System(CARDS).(02)

8. Ageing in Korean population and Dementia:Future projection and Perspective.(02)

9. Çѱ¹¾îÆÇ ³ëÀÎÁ¤½Å»óÅ°˻ç(GMS-AGECAT)ÀÇ ½Å·Úµµ ¹× Ÿ´çµµ.(02, °øÀú)

10. Dementia in an Aging and Aged Society.(02)

11. Ä¡¸Å-ÀÏÂï ¾Ë°í ¹à°Ô »ìÀÚ.(02)

12. ¸ÓÅ©¸Þ´º¾ó ³ëÀκ´ÇÐ Çѱ¹¾î ÃÊÆÇ.(03)

13. CARDS manual for neuropsychological and clinical examination for clinical and population use.(03)

14. Community study of Dementia in the Older Korean population : Inference to Epidemiological Transition in
Dementia.(03, °øÀú)

15. Cognitive Assessment & Reference Diagnosis System (CARDS): the development of a neuropsychological and clinical examination for clinic and population use.(03, °øÀú)

16. Psychogeriatrics in Korea.(03)

17. Ä¡¸Å ±â´ÉÆò°¡¸¦ À§ÇÑ Ä¡¸ÅÀå¾ÖÆò°¡Ã´µµ Çѱ¹¾îÆÇ(DAD-K)ÀÇ °³¹ß.(03)

18. Ä¡¸Å ÀÎÁöÆò°¡¸¦ À§ÇÑ ¾ËÂêÇÏÀ̸Ӻ´Æò°¡Ã´µµ Çѱ¹¾îÆÇ(ADAS-K)ÀÇ °³¹ß.(03)

19. ¸®½ºÆ丮µ·°ú ¿Ã¶õÀÚÇÉÀÇ ÈÄÇâÀû ºñ±³ ¾à¹°°æÁ¦ÇÐÀû ¿¬±¸.(03, °øÀú)

20. Ä¡¸Å Áø´ÜÀ» À§ÇÑ °³Á¤ Ä·ºê¸®Áö ÀÎÁö°Ë»ç(CAMCOG-R) Çѱ¹¾îÆÇÀÇ Ç¥ÁØÈ­.(03, °øÀú)

21. Economic and Clinical Benefits of Galantamine in the Treatment of Mild to Moderate Alzheimers Disease in a Korean Population: A 52-Week Prospective Study.(08, °øÀú)

22. A prospective, Double-blind, community-controlled comparison of three doses of galantamine in the treatment of mild to moderate AD in a Korean population.(04, °øÀú)

23. Agitated behaviours among the institutionalized elderly with dementia: Validation of the Korean version of the Cohen-Mansfield agitation inventory.(04)

24. Effect of antipsychotics on mortality in the elderly with dementia: A 1-year prospective study in a nursing home(05, °øÀú)

25. [Book Review] Assessment scales in old age psychiatry, 2nd Ed.(05)

26. Mortality in Alzheimer¡¯s disease. A comparative prospective Korean study in community and nursing home(05, °øÀú)

27. Mental health care in South Korea(05, °øÀú)

28. A community study of depression in old age.(05)

29. Comparative efficacy of risperidone versus haloperidol on BPSD(06, °øÀú)

30. Validation of the SIB for patients with AD in Korea(06, °øÀú)

31. The Economic costs of dementia in Korea, 2002(06, °øÀú)

32. Predictors of Mortality in an Aging Community-Based Cohort in Korea(06)

33 .Effect of the Apolipoprotein E4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer¡¯s disease(06, °øÀú)

34. ³ëÀκ´ ¾à¹°¿ä¹ý(06, °øÀú)/Drug therapy in Geriatrics

35. °³Á¤ Ä·ºê¸®Áö ³ëÀÎÁ¤½ÅÀå¾Ö°Ë»ç CAMDEX-R(06)

36. The economic costs of dementia in Korea.(06, °øÀú)

37. Predictors of Mortality in an Aging Community-Based Cohort in Korea.(06)

38. Eldery dementia in Korea.(07)

39. Drug therapy for Alzheimers Disease(07)

40. Mental health economics, health service provision, and the practice of geriatric psychiatry(08, °øÀú)

41. ºñ¼­¾çÀÇ °üÁ¡À¸·Î ¼­¾ç º¸±â: °³ÀÎÁß½ÉÀû ȤÀº »çȸÁß½ÉÀû?(08)/Looking at the West from the non-West: egocentric or sociocentric?

42. Ä¡¸Å¿¡ ´ëÇÑ Ç×Á¤½Åº´¾à¹°ÀÇ »ç¿ë : Simpson paradox¸¦ »ó±âÇØ¾ß ÇÑ´Ù.(09)/Use of antypical antipsychotics for dementia : Rethinking Simpson¡¯s paradox

¾ð·Ðº¸µµ